Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 8,975 | 8,558 | 7,057 | 4,396 | 6,047 |
| Cost of Goods | 4,957 | 4,790 | 3,503 | 2,530 | 2,643 |
| Gross Profit | 4,018 | 3,768 | 3,554 | 1,866 | 3,403 |
| Operating Expenses | 3,144 | 3,136 | 3,092 | 3,463 | 3,045 |
| Operating Income | 1,831 | 1,423 | 965 | -1,068 | 1,001 |
| Interest Expense | 37 | 43 | 46 | 21 | 80 |
| Other Income | 490 | 419 | 615 | 606 | 1,091 |
| Pre-tax Income | 2,283 | 1,799 | 1,534 | -483 | 2,012 |
| Income Tax | N/A | 4 | -855 | N/A | N/A |
| Net Income Continuous | 2,283 | 1,795 | 2,389 | -483 | 2,012 |
| Net Income | $2,283 | $1,795 | $2,389 | $-483 | $2,012 |
| EBITDA(a) | $2,187 | $1,780 | $1,335 | $-685 | $1,381 |